After 18 years of leading Wörwag Pharma GmbH & Co. KG, Dr. Marcus Wörwag will withdraw from the company’s Management Board as of January 2019. Marcus Wörwag will join the Advisory Board and in this function will further develop the strategic direction of the group. Managing Directors Monika Wörwag and Gerhard Mayer henceforth will lead the company together.
Marcus Wörwag, who holds a doctorate in pharmacy, takes over the family-owned pharmacies which have been founded by his father, company founder Dr. Fritz Wörwag. In 1965, Fritz Wörwag opened the city pharmacy in Stuttgart-Zuffenhausen which laid the foundation for the Wörwag Pharma company.
Prof. Dr. Roderich Thümmel, Head of Advisory Board: “On behalf of the Advisory Board of Wörwag Pharma I would like to thank Dr. Wörwag for his exceptional commitment over the last 18 years. His period of office has been marked by a remarkable growth of sales, lastly more than 210 million euros in 2018. Furthermore Dr. Wörwag has driven the international expansion of the Wörwag Pharma group in Eastern Europe, Russia, as well as Asia and Latin America. The company therefore stands on a very solid ground which will be further developed.”
